Magnesium Orotate (When ATH: A12CC09)

When ATH:
A12CC09

Pharmacological action.
Spasmolytic, , the lack of magnesium and orotic acid, antiarrhythmic, antiagregatine.

Application.

Arrhythmias, incl. ventricular arrhythmia during digitalis intoxication, acute myocardial infarction (prevention of arrhythmias), angina, incl. vasospastic, arteritis, atherosclerosis, dyslipoproteinemia, magnesium deficiency, due to increased need (Pregnancy and lactation), reduction in dietary intake or assimilation, increasing excretion (chronic diarrhea, renal dysfunction, hyperaldosteronism, hypercalcemia, hyperthyroidism, sharp increase in BCC, gipoparatireoz, glycosuria, treatment insulinorna diabeticheskogo ketoacidosis), alcoholism, incl. abstinence symptom, kaxeksija, low levels of protein in the diet and low-calorie food.

Contraindications.

Renal dysfunction, urolithiasis disease (phosphate and magnesium-calcium concretions), sinoatrial and AV block.

Side effects.

Diarrhea, atopic dermatitis.

Cooperation.

Reduces the absorption of iron, tetracycline, sodium fluoride. Reduces the degree of magnesium deficiency and the risk of associated complications when taking diuretics, aminoglycosides, cisplatin, cyclosporine, Amphotericin, pentamidine, methotrexate, laxatives.

Dosing and Administration.

Inside, with a little water, by 1 g 3 twice a day for 1 Sun, and then 0,5 g 2-3 times a day every day, Course duration not less than 6 Sun. Perhaps the long-term use.

Precautions.

In the treatment of iron supplementation, tetracycline and sodium fluoride intake of magnesium orotate to be delayed at least, than 2 no. If you experience symptoms of intestinal dyspepsia (unstable chair, diarrhea) the dose should be reduced.

Cooperation

Active substanceDescription of interaction
Amphotericin BFMR: antagonizm. Against the background of magnesium orotate decreases the risk of complications (associated with hypomagnesemia).
MethotrexateFMR: antagonizm. Against the background of magnesium orotate decreases the risk of complications (associated with hypomagnesemia).
Sodium FluorideFKV. Against the background of reduced absorption of magnesium orotate.
TetracyclineFKV. Against the background of reduced absorption of magnesium orotate.
CyclosporineFMR: antagonizm. Against the background of magnesium orotate decreases the risk of complications (associated with hypomagnesemia).
CisplatinFMR: antagonizm. Against the background of magnesium orotate decreases the risk of complications (associated with hypomagnesemia).

Back to top button